Van der Borght K - Search Results

1

BIGL: Biochemically Intuitive Generalized Loewe null model for prediction of the expected combined effect compatible with partial agonism and antagonism.

Van der Borght K, Tourny A, Bagdziunas R, Thas O, Nazarov M, Turner H, Verbist B, Ceulemans H. Van der Borght K, et al. Sci Rep. 2017 Dec 20;7(1):17935. doi: 10.1038/s41598-017-18068-5. Sci Rep. 2017. PMID: 29263342 Free PMC article.

2

VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering.

Verbist BM, Thys K, Reumers J, Wetzels Y, Van der Borght K, Talloen W, Aerssens J, Clement L, Thas O. Verbist BM, et al. Among authors: van der borght k. Bioinformatics. 2015 Jan 1;31(1):94-101. doi: 10.1093/bioinformatics/btu587. Epub 2014 Aug 31. Bioinformatics. 2015. PMID: 25178459

3

QQ-SNV: single nucleotide variant detection at low frequency by comparing the quality quantiles.

Van der Borght K, Thys K, Wetzels Y, Clement L, Verbist B, Reumers J, van Vlijmen H, Aerssens J. Van der Borght K, et al. Among authors: van vlijmen h. BMC Bioinformatics. 2015 Nov 10;16:379. doi: 10.1186/s12859-015-0812-9. BMC Bioinformatics. 2015. PMID: 26554718 Free PMC article.

4

Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab.

Casneuf T, Adams HC 3rd, van de Donk NWCJ, Abraham Y, Bald J, Vanhoof G, Van der Borght K, Smets T, Foulk B, Nielsen KC, Rusbuldt J, Axel A, Lysaght A, Ceulemans H, Stevenaert F, Usmani SZ, Plesner T, Avet-Loiseau H, Nijhof I, Mutis T, Schecter JM, Chiu C, Bahlis NJ. Casneuf T, et al. Among authors: van der borght k. Leukemia. 2021 Feb;35(2):573-584. doi: 10.1038/s41375-020-0855-4. Epub 2020 May 26. Leukemia. 2021. PMID: 32457357 Free PMC article.

5

High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.

Adams HC 3rd, Stevenaert F, Krejcik J, Van der Borght K, Smets T, Bald J, Abraham Y, Ceulemans H, Chiu C, Vanhoof G, Usmani SZ, Plesner T, Lonial S, Nijhof I, Lokhorst HM, Mutis T, van de Donk NWCJ, Sasser AK, Casneuf T. Adams HC 3rd, et al. Among authors: van de donk nwcj, van der borght k. Cytometry A. 2019 Mar;95(3):279-289. doi: 10.1002/cyto.a.23693. Epub 2018 Dec 11. Cytometry A. 2019. PMID: 30536810 Free PMC article.

6

Cross-validated stepwise regression for identification of novel non-nucleoside reverse transcriptase inhibitor resistance associated mutations.

Van der Borght K, Van Craenenbroeck E, Lecocq P, Van Houtte M, Van Kerckhove B, Bacheler L, Verbeke G, van Vlijmen H. Van der Borght K, et al. Among authors: van craenenbroeck e, van houtte m, van kerckhove b, van vlijmen h. BMC Bioinformatics. 2011 Oct 3;12:386. doi: 10.1186/1471-2105-12-386. BMC Bioinformatics. 2011. PMID: 21966893 Free PMC article.

7

Quantitative prediction of integrase inhibitor resistance from genotype through consensus linear regression modeling.

Van der Borght K, Verheyen A, Feyaerts M, Van Wesenbeeck L, Verlinden Y, Van Craenenbroeck E, van Vlijmen H. Van der Borght K, et al. Among authors: van wesenbeeck l, van craenenbroeck e, van vlijmen h. Virol J. 2013 Jan 3;10:8. doi: 10.1186/1743-422X-10-8. Virol J. 2013. PMID: 23282253 Free PMC article.

8

Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype.

Altmann A, Sing T, Vermeiren H, Winters B, Van Craenenbroeck E, Van der Borght K, Rhee SY, Shafer RW, Schülter E, Kaiser R, Peres Y, Sönnerborg A, Fessel WJ, Incardona F, Zazzi M, Bacheler L, Van Vlijmen H, Lengauer T. Altmann A, et al. Among authors: van craenenbroeck e, van vlijmen h, van der borght k. Antivir Ther. 2009;14(2):273-83. Antivir Ther. 2009. PMID: 19430102

9

Multi-model inference using mixed effects from a linear regression based genetic algorithm.

Van der Borght K, Verbeke G, van Vlijmen H. Van der Borght K, et al. Among authors: van vlijmen h. BMC Bioinformatics. 2014 Mar 27;15:88. doi: 10.1186/1471-2105-15-88. BMC Bioinformatics. 2014. PMID: 24669828 Free PMC article.

10

Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixtures.

Winters B, Van Craenenbroeck E, Van der Borght K, Lecocq P, Villacian J, Bacheler L. Winters B, et al. Among authors: van craenenbroeck e, van der borght k. J Virol Methods. 2009 Dec;162(1-2):101-8. doi: 10.1016/j.jviromet.2009.07.023. Epub 2009 Aug 3. J Virol Methods. 2009. PMID: 19654022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters